Multivariable linear regression to assess independent covariates for the BMI z score at the study end point for the SAMS trial participants with SCA and SAM who completed the trial (n = 108)
| Variable . | β . | 95% CI . | P value . |
|---|---|---|---|
| Age, y | −0.059 | From −0.110 to −0.008 | .023 |
| Sex (female) | −0.105 | From −0.301 to – 0.090 | .287 |
| Hb (g/dl) | −0.047 | From −0.143 to – 0.050 | .339 |
| Baseline BMI z score | 0.643 | From 0.424 to – 0.862 | < .001 |
| Group (RUTF plus hydroxyurea) | 0.009 | From −0.187 to – 0.205 | .928 |
| Variable . | β . | 95% CI . | P value . |
|---|---|---|---|
| Age, y | −0.059 | From −0.110 to −0.008 | .023 |
| Sex (female) | −0.105 | From −0.301 to – 0.090 | .287 |
| Hb (g/dl) | −0.047 | From −0.143 to – 0.050 | .339 |
| Baseline BMI z score | 0.643 | From 0.424 to – 0.862 | < .001 |
| Group (RUTF plus hydroxyurea) | 0.009 | From −0.187 to – 0.205 | .928 |